Taken together, NEK7 overexpression alleviated liver fibrosis induced by CCl4 and CDAHFD, suggesting that NEK7 may be a promising therapeutic target for the treatment of chronic liver fibrosis. The gene discussed is NEK7; the disease is Hepatic fibrosis.